Drugs / Salycilic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03859843 | Jan 2020 → Jan 2021 | acne | Assiut University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salycilic acid | “Chemical peeling (Salycilic acid)” NCT03859843 ↗ |
| Action | Inhibit | “penetrate comedones and pores to prevent clogging and neutralize bacteria” NCT03859843 ↗ |
| Modality | Small molecule | “SA is a 2-hydroxybenzoic acid (from willow tree) used for superficial peeling due to its strong keratolytic and comedo- lytic properties.” NCT03859843 ↗ |